Company* |
Company* |
Type/Product Area |
Terms/Details (Date) |
| |||
Biotique Systems Inc.* |
Affymetrix Inc. (AFFX) |
Affymetrix licensed the Biotique Local Integration System, a data integration solution |
Affymetrix will use the system in its research activities; terms were not disclosed (11/11) |
|
|||
Celsion Corp. (AMEX:CLN) |
Asia Pacific Life Sciences Corp. Ltd. (China) |
Joint venture to develop and distribute Celsion's products in China |
Asia Pacific Life Sciences is a group of Hong Kong-based investors; terms of the deal were not disclosed (12/15) |
|
|||
Epoch Biosciences Inc. (EBIO) |
BioControl Systems Inc.* |
Nonexclusive license to Epoch's MGB Eclipse technologies |
BioControl will use the technology in the area of food testing; Epoch will get access fees, revenues on product sales and royal- ties on resulting end-system sales (10/28) |
|
|||
Locus Pharmaceuticals Inc.* |
IBM Corp. |
Collaboration to deploy supercomputing power for research and drug design |
Locus will leverage the additional computing power to improve research efficiency; a focus is Locus' program in HIV and AIDS (12/2) |
|
|||
Panacea Pharmaceuticals Inc.* |
JSR Corp. (Japan) |
To develop and improve assays in Panacea's HAAH oncology program |
JSR will provide capabilities in magnetic particle fabrication and surface chemistries; terms were not disclosed (12/9) |
|
|||
Parallel Solutions Inc.* |
Phase III Medical Inc. (OTC BB:PHSM) |
Royalty agreement for a bioshielding technology with improved delivery of small and large molecules |
PSI would pay Phase III a percentage of revenue from the technology in exchange for capital and guidance provided by Phase III (12/12) |
|
|||
| |||
Notes: | |||
# This chart does not include agreements that involve agricultural product development. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. | |||
AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board. |